Liposomal amphotericin B (LAmB) is used in the treatment of opportunistic fungal and
parasitic infections, including leishmaniasis. Given its lack of known teratogenicity in …

Background Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis which can occur
after successful treatment of visceral leishmaniasis (VL) and is a public health problem in VL …

Background Leishmaniasis is caused by infection with intracellular protozoans of the genus
Leishmania. Transmission occurs predominantly by the bite of phlebotomine sandflies, other …

Leishmaniasis has been identified as a significant disease in tropical and subtropical
regions of the world, with Iran being one of the disease-endemic areas. Various treatments …

Introduction: Visceral leishmaniasis (VL) is a vector-borne disease caused by protozoan
parasites of the genus Leishmania. The disease is endemic in parts of South Asia, East …

• The latest Pan American Health Organization guidelines recommend using liposomal
amphotericin B (LAMB) for both immunocompetent and immunocompromised patients with …

Visceral leishmaniasis (VL), often referred to as kala-azar, is quite rare in developed
countries during pregnancy. Only few studies have evaluated its impact on perinatal …

Cutaneous leishmaniasis is a parasitic infection that causes significant maternal morbidity,
and even fetal mortality, during pregnancy, yet there are limited therapeutic options. Here …

Background Visceral leishmaniasis (VL) is a public health issue in endemic countries with
poor sanitation facilities. In this study, the seroprevalence rate and associated risk factors of …

Background: After the earthquake in 2017 a few new cases of visceral leishmaniasis (VL)
were reported from SarPol-e-Zahab district of Kermanshah Province, western part of Iran …